Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ru Guo

Showing results (1-10 of 326) with videos related to

Pageof 33
Sort By:
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|February 28, 2006
[Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 14, 2018
[Concise analysis for innovation of pioneering and follow-on drugs]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 3, 2018
[Drug innovation and reverse thinking]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 19, 2018
[On the molecular drug design from viewpoint of precision medicine]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|December 4, 2008
[Strategy of molecular drug design: hits, leads and drug candidates]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|April 19, 2012
[Modification of natural products for drug discovery]Zong-Ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|July 15, 2011
[Drug promiscuity]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|July 17, 2008
[Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule]Zong-Ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|May 20, 2009
[Strategy of molecular drug design: dual-target drug design]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|October 12, 2010
[Strategy of molecular drug design: activity and druggability]Zong-Ru Guo
Pageof 33

Showing results (1-10 of 326) with videos related to

Sort By:
Pageof 33
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|February 28, 2006
[Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 14, 2018
[Concise analysis for innovation of pioneering and follow-on drugs]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 3, 2018
[Drug innovation and reverse thinking]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 19, 2018
[On the molecular drug design from viewpoint of precision medicine]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|December 4, 2008
[Strategy of molecular drug design: hits, leads and drug candidates]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|April 19, 2012
[Modification of natural products for drug discovery]Zong-Ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|July 15, 2011
[Drug promiscuity]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|July 17, 2008
[Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule]Zong-Ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|May 20, 2009
[Strategy of molecular drug design: dual-target drug design]Zong-ru Guo
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|October 12, 2010
[Strategy of molecular drug design: activity and druggability]Zong-Ru Guo
Pageof 33